Literature DB >> 18486925

DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients.

Ying Zhou1, Qianjin Lu.   

Abstract

Systemic lupus erythematosus (SLE) is a typical autoimmune disease characterized by the production of autoantibodies and the damage of multiple organs. T lymphocytes play an important role in the autoimmune responses. Epigenetic factors have significant effects on T-cell functions by modulating its DNA methylation pattern. Gene-specific DNA hypomethylation happens in T cells in patients with active lupus. 5-azacytidine (5-azaC), and other demethylating agents like procainamide and hydralazine could induce lupus-like autoimmunity in vitro and in vivo. DNA hypomethylation in CD4+ T cell causes several gene activations and molecule overexpressions, and alters cellular function. Aberration DNA methylation in T cells might be responsible for idiopathic lupus and drug-induced lupus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486925     DOI: 10.1016/j.autrev.2008.03.003

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  24 in total

Review 1.  The epigenetics of autoimmunity.

Authors:  Francesca Meda; Marco Folci; Andrea Baccarelli; Carlo Selmi
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Drug-induced lupus erythematosus: incidence, management and prevention.

Authors:  Christopher Chang; M Eric Gershwin
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

Review 3.  Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes.

Authors:  Birgit Knoechel; Jens G Lohr
Journal:  J Autoimmun       Date:  2013-07-21       Impact factor: 7.094

Review 4.  Epigenetics of multiple sclerosis: an updated review.

Authors:  Cem İsmail Küçükali; Murat Kürtüncü; Arzu Çoban; Merve Çebi; Erdem Tüzün
Journal:  Neuromolecular Med       Date:  2014-03-21       Impact factor: 3.843

Review 5.  Clinical applications of epigenetics in cardiovascular disease: the long road ahead.

Authors:  Stella Aslibekyan; Steven A Claas; Donna K Arnett
Journal:  Transl Res       Date:  2014-04-08       Impact factor: 7.012

Review 6.  Cutting-edge issues in primary biliary cirrhosis.

Authors:  Marco Folci; Francesca Meda; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 7.  Regulation of CD4 T-cell differentiation and inflammation by repressive histone methylation.

Authors:  Frann Antignano; Colby Zaph
Journal:  Immunol Cell Biol       Date:  2015-01-13       Impact factor: 5.126

8.  The development and validation of EpiComet-Chip, a modified high-throughput comet assay for the assessment of DNA methylation status.

Authors:  Todd A Townsend; Marcus C Parrish; Bevin P Engelward; Mugimane G Manjanatha
Journal:  Environ Mol Mutagen       Date:  2017-07-29       Impact factor: 3.216

9.  Correlation between miR-126 expression and DNA hypomethylation of CD4+ T cells in rheumatoid arthritis patients.

Authors:  Ge Yang; Daoquan Wu; Guang Zeng; Ou Jiang; Pingzong Yuan; Shenjie Huang; Jing Zhu; Jie Tian; Yaguang Weng; Zhihua Rao
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 10.  Solving the genetic puzzle of systemic lupus erythematosus.

Authors:  Wanling Yang; Yu Lung Lau
Journal:  Pediatr Nephrol       Date:  2014-09-20       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.